Expression and purification of the extracellular domains of human glycoprotein VI (GPVI) and the receptor for advanced glycation end products (RAGE) from Rattus norvegicus in Leishmania tarentolae

References

• Gupta, S.K.; Shukla, P. Advanced Technologies for Improved Expression of Recombinant Proteins in Bacteria: Perspectives and Applications. Crit. Rev. Biotechnol. 2016, 36, 1089–1098.
   PubMed Web of Science ®Google Scholar
• Meehl, M.A.; Stadheim, T.A. Biopharmaceutical Discovery and Production in Yeast. Curr. Opin. Biotechnol. 2014, 30, 120–127.
   PubMed Web of Science ®Google Scholar
• Wells, E.A.; Robinson, A.S. Cellular Engineering for Therapeutic Protein Production: Product Quality, Host Modification, and Process Improvement. Biotechnol. J. 2017, 12, 1600105. doi:10.1002/biot201600105
   Web of Science ®Google Scholar
• Vega, M.C. (Ed.). Advanced Technologies for Protein Complex Production and Characterization. Advances in Experimental Medicine and Biology, 2016; 896, Springer International Publishing AG, Switzerland.
   Google Scholar
• Breitling, R.; Klingner, S.; Callewaert, N.; Pietrucha, R.; Geyer, A.; Ehrlich, G.; Hartung, R.; Müller, A.; Contreras, R.; Beverley, S.M.; Alexandrov, K. Non-pathogenic Trypanosomatid Protozoa as a Platform for Protein Research and Production. Protein Expr. Purif. 2002, 25, 209–218.
   PubMed Web of Science ®Google Scholar
• Basile, G.; Peticca, M. Recombinant Protein Expression in Leishmania tarentolae. Mol. Biotechnol. 2009, 43, 273–278.
   PubMed Web of Science ®Google Scholar
• Taheri, T.; Seyed, N.; Mizbani, A.; Rafati, S. Leishmania Based Expression Systems. Appl. Microbiol. Biotechnol. 2016, 100, 7377–7385.
   PubMed Web of Science ®Google Scholar
• Fritsche, C.; Sitz, M.; Wolf, M.; Pohl, H.-D. Development of a Defined Medium for Heterologous Expression in Leishmania tarentolae. J. Basic Microbiol. 2008, 48, 488–495.
   PubMed Web of Science ®Google Scholar
• Neeper, M.; Schmidt, A.M.; Brett, J.; Yan, S.D.; Wang, F.; Pan, Y.C.; Elliston, K.; Stern, D.; Shwa, A. Cloning and Expression of a Cell Surface Receptor for Advanced Glycosylation End Products of Proteins. J. Biol. Chem. 1992, 267, 14998–15004.
   PubMed Web of Science ®Google Scholar
• Bierhaus, A.; Humpert, P.; Morcos, M.; Wendt, T.; Chavakis, T.; Arnold, B.; Stern, D.; Nawroth, P. Understanding RAGE, the Receptor for Advanced Glycation End Products. J. Mol. Med. 2005, 83, 876–886.
   PubMed Web of Science ®Google Scholar
• Barclay, A.N. Membrane Proteins with Immunoglobulin-like Domains - A Master Superfamily of Interaction Molecules. Semin. Immunol. 2003, 15, 215–223.
   PubMed Web of Science ®Google Scholar
• Dattilo, B.M.; Fritz, G.; Leclerc, E.; Vander Kooi, C.; Heizmann, C.W.; Chazin, W.J. The Extracellular Region of the Receptor for Advanced Glycation Endproducts is Composed of Two Independent Structural Units. Biochemistry 2007, 46, 6957–6970.
   PubMed Web of Science ®Google Scholar
• Hudson, B.I.; Kalea, A.Z.; Arriero, M.M.; Harja, E.; Boulanger, E.; DÁgati, V.; Schmidt, V.M. Interaction of the RAGE Cytoplasmic Domain with Diaphanous-I is Required for Ligand-stimulated Cellular Migration Through Activation of Rac1 and Cdc42. J. Biol. Chem. 2008, 283, 34457–34468.
   PubMed Web of Science ®Google Scholar
• Schmidt, A.M.; Vianna, M.; Gerlach, M.; Brett, J.; Ryan, J.; Kao, J.; Esposito, C.; Hegarty, C.; Hurley, W.; Clauss, M. Isolation and Characterization of Two Binding Proteins for Advanced Glycosylation End Products from Bovine Lung which are Present on the Endothelial Cell Surface. J. Biol. Chem. 1992, 267, 14987–14997.
   PubMed Web of Science ®Google Scholar
• Thorpe, S.R.; Baynes, J.W. Maillard Reaction Products in Tissue Proteins: New Products and New Perspectives. Amino Acids 2003, 25, 275–281.
   PubMed Web of Science ®Google Scholar
• Sparvero, L.J.; Asafu-Adjei, D.; Kang, R.; Tang, D.; Amin, N.; Im, J.; Rutledge, R.; Lin, B.; Amoscato, A.A.; Zeh, H.J.; Lotze, M.T. RAGE (Receptor for Advanced Glycation Endproducts), RAGE Ligands, and Their Role in Cancer and Inflammation. J. Transl. Med. 2009, 7, 17.
   PubMed Web of Science ®Google Scholar
• Leclerc, E.; Fritz, G.; Vetter, S.W.; Heizmann, C.W. Binding of S100 Proteins to RAGE: An Update. Biochim. Biophys. Acta 2009, 1793, 993–1007.
   PubMed Web of Science ®Google Scholar
• Tian, J.; Avalos, A.M.; Mao, S.-Y.; Chen, B.; Senthil, K.; Wu, H.; Parroche, P.; Drabic, S.; Golenbock, D.; Sirois, C.; Hua, J.; An, L.L.; Audoly, L.; Rosa, G.A.; Bierhaus, A.; Naworth, P.; Marshak-Rothstein, A.; Crow, M.K.; Fitzgerald, K.A.; Latz, E.; Kiener, P.A.; Coyle, A.J. Toll-like Receptor 9-dependent Activation by DNA-Containing Immune Complexes is Mediated by HMGB1 an RAGE. Nat. Immunol. 2007, 8, 487–496.
   PubMed Web of Science ®Google Scholar
• Mizumoto, S.; Takahashi, J.; Sugahara, K. Receptor for Advanced Glycation End Products (RAGE) Functions as Receptor for Specific Sulfated Glycosaminoglycans, and Anti-RAGE Antibody or Sulfated Glycosaminoglycans Delivered In Vivo Inhibit Pulmonary Metastasis of Tumor Cells. J. Biol. Chem. 2012, 287, 18985–18994.
   PubMed Web of Science ®Google Scholar
• Rai, V.; Toure, F.; Chitayat, S.; Pei, R.; Song, F.; Li, Q.; Zhang, J.; Rosario, R.; Ramasamy, R.; Chazin, W.J.; Schmidt, A.M. Lysophosphatidic Acid Targets Vascular and Oncogenic Pathways Via RAGE Signaling. J. Exp. Med. 2012, 209, 2339–2350.
   PubMed Web of Science ®Google Scholar
• Xie, J.; Reverdatto, S.; Frolov, A.; Hoffmann, R.; Burz, D.S.; Shekhtman, A. Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE). J. Biol. Chem. 2008, 283, 27255–27769.
   PubMed Web of Science ®Google Scholar
• Huttunen, H.J.; Fages, C.; Rauvala, H. Receptor for Advanced Glycation End Products (RAGE)-Mediated Neurite Outgrowth and Activation of NF-κB Require the Cytoplasmic Domain of the Receptor But Different Downstream Signalling Pathways. J. Biol. Chem. 1999, 274, 19919–19924.
   PubMed Web of Science ®Google Scholar
• Riehl, A.; Nemeth, J.; Angel, P.; Hess, J. The Receptor RAGE: Bridging Inflammation and Cancer. Cell Commun. Signal. 2009, 7, 12. doi:10.1186/1478-811X-7-12
   PubMed Web of Science ®Google Scholar
• Chuah, Y.K.; Basir, R.; Talib, H.; Tie, T.H.; Nordin, N. Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases. Int. J. Inflamm. 2013, 2013, 1–15. (Article ID 403460).
   Google Scholar
• Ramasamy, R.; Shekhtman, A.; Schmidt, A.M. The Multiple Faces of RAGE - Opportunities for Therapeutic Intervention in Aging and Chronic Diseases. Expert Opin. Ther. Target. 2016, 20, 431–446.
   PubMed Web of Science ®Google Scholar
• Phillips, D.R.; Agin, P.P. Platelet Plasma Membrane Glycoproteins Identification of a Proteolytic Substrate for Thrombin. Biochem. Biophys. Res. Commun. 1977, 75, 940–947.
   PubMed Web of Science ®Google Scholar
• Moroi, M.; Jung, S.M.; Okuma, M.; Shinmyozu, K. A Patient with Platelets Deficient in Glycoprotein VI that Lack Both Collagen-induced Aggregation and Adhesion. J. Clin. Invest. 1989, 84, 1440–1445.
   PubMed Web of Science ®Google Scholar
• Knight, C.G.; Morton, L.F.; Onley, D.J.; Peachey, A.R.; Ichinohe, T.; Okuma, M.; Farndale, R.W.; Barnes, M.J. Collagen-platelet Interaction: Gly-Pro-Hyp is Uniquely Specific for Platelet Gp VI and Mediates Platelet Activation by Collagen. Cardiovasc. Res. 1999, 41, 450–457.
   PubMed Web of Science ®Google Scholar
• Clemetson, J.M.; Polgar, J.; Magnenat, E.; Wells, T.N.; Clemetson, K.J. The Platelet Collagen Receptor Glycoprotein VI is a Member of the Immunoglobulin Superfamily Closely Related to Fcα R and the Natural Killer Receptors. J. Biol. Chem. 1999, 274, 29019–29024.
   PubMed Web of Science ®Google Scholar
• Moroi, M.; Jung, S.M. Platelet Glycoprotein VI: Its Structure and Function. Thrombosis Res. 2004, 114, 22–233.
   Web of Science ®Google Scholar
• Dütting, S.; Bender, M.; Nieswandt, B. Platelet GPVI: A Target for Antithrombotic Therapy ?! Trends Pharmacol. Sci. 2012, 33, 583–590.
   PubMed Web of Science ®Google Scholar
• Yun, S.H.; Sim, E.H.; Goh, R.Y.; Park, J.I.; Han, J.Y. Platelet Activation: The Mechanism and Potential Biomarkers. BioMed Res. Int. 2016, 2016, 1–5. (Article ID 9060143).
   Web of Science ®Google Scholar
• Minton, A.P. Recent Applications of Light Scattering Measurements in the Biological and Biopharmaceutical Sciences. Anal. Biochem. 2016, 501, 4–22.
   PubMed Web of Science ®Google Scholar
• Srikrishna, G.; Huttunen, H.J.; Johansson, L.; Weigle, B.; Yamaguchi, Y.; Rauvala, H.; Freeze, H.H. N-Glycans on the Receptor for Advanced Glycation End Products Influence Amphoterin Binding and Neurite Outgrowth. J. Neurobiol. 2002, 80, 998–1008.
   Google Scholar
• Lecut, C.; Arocast, V.; Ulrichts, H.; Elbaz, A.; Villevall, J.L.; Lacapere, J.J.; Deckmyn, H.; Jandrot-Perrust, M. Identification of Residues Within Human Glycoprotein VI Involved in the Binding to Collagen. J. Biol. Chem. 2004, 279, 52293–52299.
   PubMed Web of Science ®Google Scholar
• Fritsche, C.; Sitz, M.; Weiland, N.; Breitling, R.; Pohl, H.D. Characterization of the Growth Behavior of Leishmania tarentolae - A New Expression System for Recombinant Proteins. J. Basic Microbiol. 2007, 47, 384–393.
   PubMed Web of Science ®Google Scholar
• Klatt, S.; Rohe, M.; Alagesan, K.; Kolarich, D.; Konthur, Z.; Hartl, D. Production of Glycosylated Soluble Amyloid Precursor Protein Alpha (sAPPalpha) in Leishmania tarentolae. J. Proteome Res. 2013, 12, 396–403.
   PubMed Web of Science ®Google Scholar
• Phan, H.P.; Sugino, M.; Niimi, T. The Production of Recombinant Human Laminin-322 in a Leishmania tarentolae Expression System. Prot. Expr. Purif. 2009, 68, 79–84.
   PubMed Web of Science ®Google Scholar
• Pion, C.; Courtois, V.; Husson, S.; Bernard, M.C.; Nicolai, M.C.; Talaga, P.; Trannoy, E.; Moste, C.; Sodoyer, R.; Legastelois, I. Characterization and Immunogenicity in Mice of Recombinant Influenza Haemagglutinins Produced in Leishmania tarentolae. Vaccine 2014, 32, 5570–5576.
   PubMed Web of Science ®Google Scholar
• Grzyb, K.; Czarnota, A.; Brzozowska, A.; Cieslik, A.; Rabalski, L.; Tyborowska, J.; Bienkowska-Szewczyk, K. Immunogenicity and Functional Characterization of Leishmania-derived Hepatitis C Virus Envelope Glycoprotein Complex. Sci. Reports 2016, 6, 30626 doi:10.1038/srep30627
   PubMed Web of Science ®Google Scholar